# Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients

> **NCT01401010** · PHASE4 · COMPLETED · sponsor: **Gary E. Stein, Pharm.D.** · enrollment: 12 (actual)

## Conditions studied

- Febrile Neutropenia

## Interventions

- **DRUG:** Doripenem
- **DRUG:** doripenem

## Key facts

- **NCT ID:** NCT01401010
- **Lead sponsor:** Gary E. Stein, Pharm.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01401010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01401010, "Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01401010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*